Is angiogenesis an organizing principle in biology and medicine?

[1]  J. Folkman,et al.  Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[3]  L. Kaban,et al.  Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[4]  J. Folkman,et al.  Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. , 1990, Growth factors.

[5]  R. D'Amato,et al.  Thalidomide therapy for Crohn's disease , 2000 .

[6]  R. Baserga,et al.  Cell cycle and growth control. , 1993, Critical reviews in eukaryotic gene expression.

[7]  R. D'Amato,et al.  Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. , 2006, Fertility and sterility.

[8]  J. Folkman,et al.  A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. , 2005, Cancer research.

[9]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[10]  P. Lipsky,et al.  Targeted Therapies in Rheumatology , 2002 .

[11]  J. Folkman,et al.  Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. , 2001, Journal of the National Cancer Institute.

[12]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[13]  J. Davies,et al.  Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 , 2004, Nature Medicine.

[14]  J. Folkman,et al.  Fighting cancer by attacking its blood supply. , 1996, Scientific American.

[15]  F. Becker,et al.  Growth and metastasis of tumor in organ culture , 1963, Cancer.

[16]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[17]  E. Copeland,et al.  Book Review The Breast: Comprehensive management of benign and malignant diseases Second edition. Edited by Kirby I. Bland and Edward M. Copeland III. 1631 pp. in two volumes, illustrated. Philadelphia, W.B. Saunders, 1998. $225. 0-7216-6656-6 , 1999 .

[18]  Susan M. Kilroy,et al.  Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies , 2005, Pediatrics.

[19]  Amanda J. Thomas,et al.  A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer , 2005, Journal of pediatric hematology/oncology.

[20]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[21]  R. Timpl,et al.  Zinc-dependent dimers observed in crystals of human endostatin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Judah Folkman,et al.  Angiogenesis in vitro , 1980, Nature.

[23]  D. Hanahan,et al.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma , 1991, Cell.

[24]  J. Folkman.  Discussion: Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws☆ , 2002 .

[25]  J. Folkman,et al.  Preservation of Vascular Integrity in Organs perfused in vitro with a Platelet-rich Medium , 1969, Nature.

[26]  P. Hahnfeldt,et al.  Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. , 2003, Journal of theoretical biology.

[27]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[28]  J. Folkman,et al.  Long-term culture of capillary endothelial cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Jain,et al.  Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Folkman,et al.  Protamine is an inhibitor of angiogenesis , 1982, Nature.

[31]  J. Folkman,et al.  The sequence of events in the regression of corneal capillaries. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[32]  P. Black,et al.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours , 1994, The Lancet.

[33]  D. Ingber,et al.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.

[34]  J. Folkman,et al.  Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. , 1993, Cancer research.

[35]  J. Folkman,et al.  Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[37]  P. Hahnfeldt,et al.  Antiangiogenic Therapy and p53 , 2002, Science.

[38]  J. Folkman.  Endogenous angiogenesis inhibitors , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[39]  J. Folkman,et al.  TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION , 1972, The Journal of experimental medicine.

[40]  R. D'Amato,et al.  2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Gabriel S. Eichler,et al.  Evidence by molecular profiling for a placental origin of infantile hemangioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[43]  J. Palmblad,et al.  Angiogenesis Research: Guidelines for Translation to Clinical Application , 2001, Thrombosis and Haemostasis.

[44]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[45]  J. Folkman,et al.  New Approach to Analgesia and Anesthesia Anesthesia by Diffusion through Silicone Rubber , 1968 .

[46]  A. Giaccia,et al.  Antiangiogenic therapy and p53. , 2002, Science.

[47]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[48]  J. Folkman,et al.  Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.

[49]  J. Folkman,et al.  Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.

[50]  J. Folkman,et al.  THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. , 1964, The Journal of surgical research.

[51]  J. Folkman,et al.  A family of angiogenic peptides , 1987, Nature.

[52]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[53]  J. Folkman.  Successful treatment of an angiogenic disease. , 1989, The New England journal of medicine.

[54]  J. Debus,et al.  Endostatin's antiangiogenic signaling network. , 2004, Molecular cell.

[55]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[56]  Raghu Kalluri,et al.  Cancer without disease , 2004, Nature.

[57]  Judah Folkman,et al.  Thalidomide is an inhibitor of angiogenesis. , 1994 .

[58]  D. Mukhopadhyay,et al.  Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. , 2005, Cancer cell.

[59]  J. Folkman,et al.  Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. , 2000, Cancer research.

[60]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[61]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[62]  Lars Holmgren,et al.  Horizontal transfer of oncogenes by uptake of apoptotic bodies , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[64]  J. Mulliken,et al.  Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases. , 2002, Pediatrics.

[65]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[66]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.